454 related articles for article (PubMed ID: 35157072)
21. Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Kandi V; Thungaturthi S; Vadakedath S; Gundu R; Mohapatra RK
Cureus; 2021 Mar; 13(3):e14081. PubMed ID: 33903841
[TBL] [Abstract][Full Text] [Related]
22. Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a "non-COVID" hospital in Mexico City.
Cruz-Arenas E; Cabrera-Ruiz E; Laguna-Barcenas S; Colin-Castro CA; Chavez T; Franco-Cendejas R; Ibarra C; Perez-Orive J
PLoS One; 2021; 16(8):e0255916. PubMed ID: 34383842
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Infection Fatality Rate Associated with Incidence-A Population-Level Analysis of 19 Spanish Autonomous Communities.
Kenyon C
Biology (Basel); 2020 Jun; 9(6):. PubMed ID: 32560071
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
Marra V; Quartin M
Int J Infect Dis; 2021 Oct; 111():190-195. PubMed ID: 34390858
[TBL] [Abstract][Full Text] [Related]
25. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
Levin AT; Hanage WP; Owusu-Boaitey N; Cochran KB; Walsh SP; Meyerowitz-Katz G
Eur J Epidemiol; 2020 Dec; 35(12):1123-1138. PubMed ID: 33289900
[TBL] [Abstract][Full Text] [Related]
26. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
Pastor-Barriuso R; Pérez-Gómez B; Hernán MA; Pérez-Olmeda M; Yotti R; Oteo-Iglesias J; Sanmartín JL; León-Gómez I; Fernández-García A; Fernández-Navarro P; Cruz I; Martín M; Delgado-Sanz C; Fernández de Larrea N; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Larrauri A; Pollán M;
BMJ; 2020 Nov; 371():m4509. PubMed ID: 33246972
[TBL] [Abstract][Full Text] [Related]
27. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
[TBL] [Abstract][Full Text] [Related]
28. Age-stratified infection fatality rate of COVID-19 in the non-elderly population.
Pezzullo AM; Axfors C; Contopoulos-Ioannidis DG; Apostolatos A; Ioannidis JPA
Environ Res; 2023 Jan; 216(Pt 3):114655. PubMed ID: 36341800
[TBL] [Abstract][Full Text] [Related]
29. Infection fatality rate of COVID-19 in community-dwelling elderly populations.
Axfors C; Ioannidis JPA
Eur J Epidemiol; 2022 Mar; 37(3):235-249. PubMed ID: 35306604
[TBL] [Abstract][Full Text] [Related]
30. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
Skowronski DM; Kaweski SE; Irvine MA; Chuang ESY; Kim S; Sabaiduc S; Reyes RC; Henry B; Sekirov I; Smolina K
CMAJ; 2023 Oct; 195(42):E1427-E1439. PubMed ID: 37903524
[TBL] [Abstract][Full Text] [Related]
31. Estimating the wave 1 and wave 2 infection fatality rates from SARS-CoV-2 in India.
Purkayastha S; Kundu R; Bhaduri R; Barker D; Kleinsasser M; Ray D; Mukherjee B
BMC Res Notes; 2021 Jul; 14(1):262. PubMed ID: 34238344
[TBL] [Abstract][Full Text] [Related]
32. Infection fatality rate and infection attack rate of COVID-19 in South American countries.
Musa SS; Tariq A; Yuan L; Haozhen W; He D
Infect Dis Poverty; 2022 Apr; 11(1):40. PubMed ID: 35382879
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
34. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Erikstrup C; Hother CE; Pedersen OBV; Mølbak K; Skov RL; Holm DK; Sækmose SG; Nilsson AC; Brooks PT; Boldsen JK; Mikkelsen C; Gybel-Brask M; Sørensen E; Dinh KM; Mikkelsen S; Møller BK; Haunstrup T; Harritshøj L; Jensen BA; Hjalgrim H; Lillevang ST; Ullum H
Clin Infect Dis; 2021 Jan; 72(2):249-253. PubMed ID: 33501969
[TBL] [Abstract][Full Text] [Related]
35. Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations.
Ioannidis JPA
Eur J Clin Invest; 2021 May; 51(5):e13554. PubMed ID: 33768536
[TBL] [Abstract][Full Text] [Related]
36. Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.
Basto-Abreu A; Carnalla M; Torres-Ibarra L; Romero-Martínez M; Martínez-Barnetche J; López-Martínez I; Aparicio-Antonio R; Shamah-Levy T; Alpuche-Aranda C; Rivera JA; Barrientos-Gutierrez T;
Nat Commun; 2022 Feb; 13(1):589. PubMed ID: 35105873
[TBL] [Abstract][Full Text] [Related]
37. Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County-Results from a Population-Based Longitudinal Study in Germany.
Einhauser S; Peterhoff D; Beileke S; Günther F; Niller HH; Steininger P; Knöll A; Korn K; Berr M; Schütz A; Wiegrebe S; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K; Wagner R
Viruses; 2022 May; 14(6):. PubMed ID: 35746640
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020.
Molenberghs G; Faes C; Verbeeck J; Deboosere P; Abrams S; Willem L; Aerts J; Theeten H; Devleesschauwer B; Bustos Sierra N; Renard F; Herzog S; Lusyne P; Van der Heyden J; Van Oyen H; Van Damme P; Hens N
Euro Surveill; 2022 Feb; 27(7):. PubMed ID: 35177167
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
[TBL] [Abstract][Full Text] [Related]
40. No Effects of Meteorological Factors on the SARS-CoV-2 Infection Fatality Rate.
Solanes A; Laredo C; Guasp M; Fullana MA; Fortea L; Garcia-Olivé I; Solmi M; Shin JI; Urra X; Radua J
Biomed Environ Sci; 2021 Nov; 34(11):871-880. PubMed ID: 34955147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
